How can research ethics committees protect patients better?
- 29 May 2003
- Vol. 326 (7400), 1199-1201
- https://doi.org/10.1136/bmj.326.7400.1199
Abstract
The duties of research ethics committees are becoming increasingly difficult—what skills and knowledge do their members need to evaluate protocols that contain elements that are not in the patient's interests?This publication has 23 references indexed in Scilit:
- Body Weight Changes Associated With PsychopharmacologyPsychiatric Services, 2002
- Placebo-controlled trials and the Declaration of HelsinkiThe Lancet, 2002
- Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre studyThe Lancet, 2002
- Learning from the cerivastatin experienceThe Lancet, 2001
- Estimating the consequences of anti-psychotic induced weight gain on health and mortality ratePsychiatry Research, 2001
- Treatment of Suicidality in SchizophreniaAnnals of the New York Academy of Sciences, 2001
- Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysisBMJ, 2000
- Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific IssuesAnnals of Internal Medicine, 2000
- Does placebo help establish equivalence in trials of new antidepressants?European Psychiatry, 2000
- Inconclusive messages from equivalence trials in thrombolysisHeart, 1999